2012Zhongguo yaofangRequires access

Study on Bioequivalence of 2 Kinds of Ribavirin Preparations in Human Volunteers

Dawei Xiao

Open publisher page 0 citations

Abstract

OBJECTIVE:To study bioequivalence of 2 kinds of ribavirin preparations.METHODS:In randomized crossover design,the plasma concentration of ribavirin in 20 healthy volunteers was determined by LC-MS after oral administration of Ribavirin effervescent tablet 150 mg(test preparation) and Ribavirin granules(reference preparation),and the major pharmacokinetic parameters were calculated.RESULTS:The main pharmacokinetic parameters of test preparation vs.reference preparation were as follows:t1/2(44.00±8.75)h vs.(44.89±10.44)h;tmax(1.0±0.7) h vs.(0.8±0.2) h;cmax(424.12±133.03)ng·mL-1 vs.(406.09±108.22)ng·mL-1;AUC0~108 h(4 997.59±1 322.31)ng·h·mL-1 vs.(4 921.16±1 030.61)ng·h·mL-1.The relative bioavailability of test tablet was(105.4±37.4)% by AUC0~108 h.The statistical result showed that there was no significant difference between 2 preparations in the t1/2,cmax,tmax,AUC0~108 h.CONCLUSION:The method is specific,sensitive and accurate.The two preparations are bioequivalent.

About this research paper

What this paper is about

OBJECTIVE:To study bioequivalence of 2 kinds of ribavirin preparations.METHODS:In randomized crossover design,the plasma concentration of ribavirin in 20 healthy volunteers was determined by LC-MS after oral administration of Ribavirin effervescent tablet 150 mg(test preparation) and Ribavirin granules(reference preparation),and the major pharmacokinetic parameters were calculated.RESULTS:The main pharmacokinetic parameters of test preparation vs.reference preparation were as follows:t1/2(44.00±8.75)h vs.(44.89±10.44)h;tmax(1.0±0.7) h vs.(0.8±0.2) h;cmax(424.12±133.03)ng·mL-1 vs.(406.09±108.22)ng·mL-1;AUC0~108 h(4 997.59±1 322.31)ng·h·mL-1 vs.(4 921.16±1 030.61)ng·h·mL-1.The relative bioavailability of test tablet was(105.4±37.4)% by AUC0~108 h.The statistical result showed that there was no significant difference between 2 preparations in the t1/2,cmax,tmax,AUC0~108 h.CONCLUSION:The method is specific,sensitive and accurate.The two preparations are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To study bioequivalence of 2 kinds of ribavirin preparations.METHODS:In randomized crossover design,the plasma concentration of ribavirin in 20 healthy volunteers was determined by LC-MS after oral administration of Ribavirin effervescent tablet 150 mg(test preparation) and Ribavirin granules(reference preparation),and the major pharmacokinetic parameters were calculated.RESULTS:The main pharmacokinetic parameters of test preparation vs.reference preparation were as follows:t1/2(44.00±8.75)h vs.(44.89±10.44)h;tmax(1.0±0.7) h vs.(0.8±0.2) h;cmax(424.12±133.03)ng·mL-1 vs.(406.09±108.22)ng·mL-1;AUC0~108 h(4 997.59±1 322.31)ng·h·mL-1 vs.(4 921.16±1 030.61)ng·h·mL-1.The relative bioavailability of test tablet was(105.4±37.4)% by AUC0~108 h.The statistical result showed that there was no significant difference between 2 preparations in the t1/2,cmax,tmax,AUC0~108 h.CONCLUSION:The method is specific,sensitive and accurate.The two preparations are bioequivalent.

Key concepts: Bioequivalence, Cmax, Bioavailability, Ribavirin, Pharmacokinetics, Pharmacology, Crossover study, Chromatography

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on Bioequivalence of 2 Kinds of Ribavirin Preparations in Human Volunteers — Research Paper | ScholarLens